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Diabetes is a chronic disease affecting millions of people in the world. Regular insulin 
injection therapy is now practiced for maintaining blood glucose level within 
normoglycemic range (70-100 mg/dl) in Type I diabetics having insulin dependent 
diabetes mellitus. Controllers for automatic monitoring and regulation of blood 
glucose in diabetics have been investigated. In this study, several model-based 
controllers including the ubiquitous proportional-integral-derivative (PID) controllers 
are designed for specifying insulin dosage in Type I diabetics. The study employs a 
recently reported and detailed physiological model of a diabetic along with a meal 
disturbance model. The performance and robustness of designed controllers are 
evaluated on 577 diabetic patient models generated by considering ±40% variation in 
the significant parameters of the physiological model. 
 
The detailed physiological model of the diabetic is successfully implemented and 
validated for use in evaluating the designed controllers. An internal model controller 
(IMC) is designed based on a first order plus time delay (FOPTD) model 
approximation of the detailed physiological model of the nominal diabetic. Enhanced 
internal model controller (EIMC) is then developed due to its simple structure, better 
disturbance attenuation and uncertainty reduction. Both these controllers are assessed 
for their ability to track the normoglycemic set point of 81.1 mg/dl for blood glucose 
while rejecting meal disturbances both in the nominal patient case and 577 perturbed 
patient models. The results show that EIMC performs better than IMC as well as the 
robust H∞ controller (Parker et al., 2000) for blood glucose regulation in Type I 
diabetics. 
                                                                                                                        Summary 
 
Noting that the ubiquitous PID controllers have not been tested on the detailed 
physiological model employed in this study, several PID controllers are designed 
using classical and recent tuning techniques. A secondary objective for this part of the 
study is to analyze the effectiveness of the recent tuning techniques for PID 
controllers for challenging biomedical applications such as diabetes control. Detailed 
results of testing the PID controllers designed on the perturbed patient models for 
meal disturbance rejection, show that the PID tuning by Shen (2002) is the best 
among the four tuning techniques tested. It is able to maintain the glucose 
concentration above the hypoglycemic range (hypoglycemia occurs when blood 
glucose concentration is less than 60 mg/dl) in 95% of all the 577 patient models 
considered while rejecting both single and multiple meal disturbances in a day. 
 
A nonlinear internal model controller (NIMC) using input-output linearization is 
developed for a Type I diabetic. Although this controller showed promising results for 
rejecting meal disturbances in the case of nominal patient model, spikes in the 
controlled variable (i.e., insulin injected) made it impossible to test NIMC for all the 
577 perturbed patient models. The reason for spikes seems to be numerical errors, and 
further investigation is needed to confirm this. 
 
In summary, several model based controllers (namely, IMC, EIMC, PID and NIMC) 
are designed and evaluated for blood regulation in Type I diabetic. Among these, 
EIMC and PID controller tuned by Shen's technique have performed better than the 
robust H∞ controller which itself was shown to be better than the computationally-
intensive model predictive controller (Parker et al., 2000). Considering this and the 
 vi
                                                                                                                        Summary 
simplicity of EIMC and PID controller, it is concluded that these “simpler” controllers 
may be an attractive alternative over the more complex controllers for glucose 
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At the interface between biological sciences and engineering disciplines can be found 
an interesting set of problems most easily classified as biosystems. Further 
subdivision of these systems yields problems addressing biomedical and biotechnical 
issues. Biomedical is related to medicine or the human patient, whereas the 
biotechnical issues deal with non-human or exvivo organisms. These biosystems offer 
a challenging set of modeling and regulation problems to the biological, medical and 
engineering communities. Biomedical problem of glucose regulation using different 
control strategies in diabetes patients is the focus of this study. 
 
Diabetes mellitus is a global, public health problem and a leading cause of morbidity 
and mortality in many parts of the world. Diabetes is of two types, Type I & Type II. 
Type 1 diabetes, formerly called juvenile diabetes or insulin dependent diabetes 
mellitus (IDDM), is usually diagnosed in children, teenagers, or young adults. In Type 
I diabetic, the glucose concentration is elevated beyond the normoglycemic range   
(70-100 mg/dl) due to the insufficient insulin secretion from the β-cells of islets of 
Langerhans present in the pancreas. Type 2 diabetes, formerly called adult-onset 
diabetes or non insulin dependent diabetes mellitus (NIDDM), is the most common 
form of diabetes. People can develop Type 2 diabetes at any age - even during 
childhood. This form of diabetes usually begins with insulin resistance, a condition in 
which fat, muscle and liver cells do not use insulin properly. The role of pancreas in 
the healthy person for the regulation of the blood glucose levels is depicted in Fig. 1.1. 
                                                                                               Chapter 1: Introduction 
 
Fig. 1.1. Regulation of Blood Glucose by Insulin and Glucagon in a Healthy Person 
 
As shown in Fig.1.1, the blood glucose level is regulated via two paths. Firstly when 
the glucose levels falls due to physical activity (e.g. exercise), it stimulates α-cells of 
pancreas which turn signals the liver to deliver the stored glucose (i.e. glucagon) into 
the blood stream to maintain the glucose concentration in the normoglycemic range 
(Glucose Concentration of 70-100 mg/dl). Secondly, when the blood glucose level 
rises by meal intake, it stimulates the β-cells of pancreas to release insulin. Insulin 
acts as a funnel for glucose to enter cells, and glucose is taken up by cells to return to 
normoglycemic range. Malfunctioning of pancreas is the cause for diabetes. Due to 
that, glucose level goes beyond the normoglycemic range in diabetics. In such patients, 
monitoring the glucose level and administering insulin are vital. Present study is to 
develop closed loop devices (referred as artificial β-cells) to mimic the action of 
pancreas. 
  
1.1 Diabetes Mellitus 
The medical name for diabetes, diabetes mellitus, comes from words with Greek and 
Latin roots. Diabetes comes from a Greek word that means to siphon. The most 
 2
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obvious sign of diabetes is excessive urination. Water passes through the body of a 
person with diabetes as if it were being siphoned from the mouth through the urinary 
system out of the body. Mellitus comes from a Latin word that means sweet like 
honey. The urine of a person with diabetes contains extra sugar (glucose) and tastes 
as sweet like honey. Insulin is a hormone produced in the pancreas to regulate the 
amount of sugar in the blood. In persons with diabetes, the pancreas produces no 
insulin, too little insulin to control blood sugar or defective insulin.  
 
The normal human body requires blood glucose concentrations of between 70 and 100 
mg/dl (milligrams of glucose in 100 milliliters of blood), which is termed as 
normoglycemic region in the medical literature. The condition of blood glucose 
concentrations of below 60 mg/dl is termed ‘hypoglycemia’, and above 110 mg/dl 
after 2 to 3 hours from eating a meal, is considered abnormal. Hypergylcaemia is a 
condition when the blood glucose exceeds 180 mg/dl at any time. Blood sugar can 
occasionally fall below 60 mg/dl and even to below 50 mg/dl and still not indicate a 
serious abnormality or disease. Blood sugar levels below 45 mg/dl are almost always 
associated with a serious abnormality. 
 
1.2 Modeling Literature 
Various models developed for the human glucose-insulin system in whole or in part, 
are comprehensively reviewed by Parker (1999). Here, only the most relevant and 
important works are briefly described. The first modeling study of the diabetic is the 
work of Bolie (1961) who developed a two state linear model consisting of two 
differential equations, one for glucose and other for insulin. A model with similar 
structure was developed by Ackerman et al. (1965) for glucose-insulin dynamics in a 
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healthy person. Even though these models with two linear equations are 
oversimplification of the physiological glucose and insulin effects, the interaction 
effects of glucose and insulin were concluded from these studies. Primitive but 
detailed physiological (organ-derived model divisions) structures were developed for 
glucose dynamics (Tiran et al., 1975) and insulin dynamics (Tiran et al., 1979) 
including nonlinear effects in the glucose metabolism. These models accounted for 
the distribution of insulin and glucose throughout the body compared to the earlier 
approaches of Bolie (1961) and Ackerman et al. (1965), but they were unable to 
capture the threshold metabolic behavior of the physiological system. 
 
Bergman et al. (1981) have developed a “minimal” model with three compartments as 
a lumped representation of the human body. The underlying dynamics of the glucose 
transport and distribution throughout the tissues were neglected by grouping these 
effects into a few parameters. The effects of glucagon, which raises the blood glucose 
concentration, were not accounted explicitly. Inadequacies of the “minimal” model 
were demonstrated in the literature (Quon et al., 1994; Weber et al., 1989).  
 
Cobelli et al. (1982) have studied the glucose and insulin modeling extensively. These 
models utilized 5-compartment models for insulin, and glucose and glucagon effects, 
each lumped into its own whole-body blood pool. These nonlinear models included 
the use of threshold functions (hyperbolic tangents) to describe the saturation 
behavior seen in biological sensing (e.g. hepatic glucose production). Validation of 
these mathematical models with a case study on glucose regulation was performed 
(Cobelli and Mari, 1983). Comparison of the peripheral versus portal route for insulin 
administration in closed-loop glucose control was done by Cobelli and              
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Ruggeri (1983). In peripheral route, insulin is injected through subcutaneous tissue, 
where as in portal route, it is administered through the vein. They found portal vein 
insulin administration to diabetics accurately matches their glucose profiles to those 
of healthy persons. However, models of Cobelli and co-workers were unable to 
describe the glucose distribution throughout the body. 
 
Puckett (1992) presented detailed modeling study of diabetes mellitus; the time scale 
of interest was much larger than that for the equilibration of glucose and insulin 
across the blood-tissue boundary, as determined from the blood perfusion data. In this 
work, the body was modeled as a two-blood-pool system representing insulin and 
glucose concentrations. The metabolic flux terms and exogenous signals directly 
affected the blood pool concentrations. Nonlinear metabolic behavior of the glucose 
insulin system was accounted, but the steady state compartmental representation 
neglects any high-frequency dynamics within the patient. Inclusion of carrier 
mechanism and diffusion pathways improved the accuracy of the glucose and insulin 
removal from the bloodstream. Puckett and Lightfoot (1995) have demonstrated both 
inter-and intrapatient variability (i.e. the differences in the dynamics of insulin and 
glucose profiles in different patients and the same patient over time) and steady state 
behavior by using their models. Variability is a challenging feature that needs to be 
addressed in both modeling and control of diabetics. 
 
A physiologically based compartmental model of glucose and insulin dynamics was 
developed by Sorensen (1985), based on an earlier model by Guyton et al. (1978). In 
this model, glucose and insulin are treated separately, with coupling through 
metabolic effects utilizing threshold functions similar to those of Cobelli et al. (1982). 
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A lumped whole body representation for glucagon was included to complete the 
glucose-insulin system with counter regulation. Parker (1999) modified the           
Sorensen (1985) model to include meal disturbances as well as parameters for 
uncertainty analysis. This complete model is described in Chapter 2, and is used for 
the controller synthesis and analysis in the present study. 
 
Lehmann and Deutsch (1992) developed a nonlinear model of glucose and insulin 
kinetics within the diabetic. The glucose sub-model was a single compartment extra 
cellular pool, from which glucose could be added or removed via metabolic processes 
and meal consumption. A two-compartment model of insulin representing plasma and 
“active” concentrations was developed. This “active” insulin compartment was 
responsible for regulating insulin-dependent glucose uptake. A generalized meal 
model was also developed by Lehmann and Deutsch (1992) as a trapezoidal 
waveform representative of a relatively constant glucose supply to the gut during 
carbohydrate absorption in series with a first order transfer function, which 
approximated the absorption kinetics of glucose by the blood stream. This allowed 
treatment of arbitrary meal sizes in disturbance rejection scenarios, which are highly 
relevant to the diabetic modeling and control. This generalized meal model is 
included in the diabetic model, as described in Chapter 2.  
 
1.3 Control Literature 
Several control algorithms were developed and studied for different models of 
diabetic in the literature. These are comprehensively reviewed by Parker (1999) and 
Parker et al. (2001). The earliest diabetes regulation work dates to the “BIOSTATOR” 
algorithm and device of Clemens (1979). This feedback controller utilized a low 
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volume continuous flow blood glucose sampling mechanism with a dual infusion 
system (insulin and dextrose) to maintain blood glucose concentration at a user-
defined value. The multichannel nature of the algorithm could lead to interactions 
such as an increase in glucose stimulates the insulin release from its reservoir leading 
to lowering of glucose level which stimulates the dextrose release from its reservoir 
and continuation of this cycle. This system requires implantation of two reservoirs, 
and is difficult due to additional size of the second depot and patient specific requiring 
individualization prior to implementation. Sorenson (1985) tested an IMC strategy on 
his model for a particular set of patient parameters. 
 
Optimal control theory was applied to the “minimal” model of Bergman et al. (1981) 
in two different studies (Ollerton, 1989; Fischer, 1991). Ollerton (1989) used an 
integral squared error cost function based on deviation from the desired glucose value. 
Sampling times of 10 and 180 min were studied. The longer sampling time had a 
longer rise time and was less sensitive to noise about the basal state, but could miss 
significant disturbances which occurred in the inter-sample window. With sampling 
time of 10 min, the controller was sensitive to oscillations of the glucose profiles 
about the basal state, and resulted in physiologically unrealistic insulin profiles 
characterized by high amplitude sustained oscillations (ringing). An insensitive model 
was introduced by Ollerton (1989), most likely based on a type of dead-band control, 
but no method for development of the insensitive model was discussed. 
 
Fischer (1991) applied optimal control theory to “minimal” model by using integral 
squared error (ISE) based objective function. The deviations in the glucose 
concentration from the set point are minimized. As a second objective the amount of 
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insulin to perform the corrective action is minimized. The study examined three 
insulin infusion profiles, determining that an initial injection plus optimal hourly 
infusion minimizes the cost function for an initially hyperglycemic patient. This 
control design also suffered from long sampling time (180 min) problem of missing 
fast or inter-sample distribution and was not robust to patient uncertainty, as in 
Ollerton (1989). 
 
Proportional Derivative (PD) and Proportional Integral (PI) type controllers 
(belonging to the Proportional-Integral-Derivative (PID) controller family) are 
employed by Fischer et al. (1990) and Chee et al. (2003) respectively for blood 
glucose control. Chee et al. (2003) have developed a PI controller to specify the 
amount of insulin to be injected based on glucose measurement in a real time manner 
by continuous glucose monitoring system (CGMS). This closed loop control was 
clinically tested on five patients and was able to control only one patient’s glycaemia 
without manual intervention. Even though manual intervention is due to the real time 
sensor reading, refinement of the algorithm and sensor accuracy are needed. 
 
Parker et al. (1999) have done an extensive study on blood glucose control and 
compared the performance of several model predictive controllers such as discrete 
IMC, Model Predictive Controller (MPC), Model Predictive Controller with State 
Estimation (MPCSE), Nonlinear Quadratic Dynamic Matrix Control with State 
Estimation (NLQDMCSE). Camelia and Doyle (2001) used IMC framework to 
maintain the blood glucose concentration in diabetics simulated by Bergman and 
Automated Insulin Dosage Advisor (AIDA) of Lehmann and Deutsch (1992) models. 
In the synthesis and/or evaluation of these controllers, however, the inherent 
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uncertainty in the model has not been addressed. Such control strategies could lead to 
significant performance degradation in the presence of inevitable patient-model 
mismatch.  
 
Significant inter- and intra-patient variability has been documented in the literature 
(Simon et al., 1987; Steil et al., 1994; Puckett and Lightfoot, 1995; Bremer and 
Gough, 1999). The control algorithm employed for blood glucose regulation must be 
able to compensate for the uncertainty that exists between the model used in the 
controller design and the actual patient. Keinitz and Yoneyama (1993) used the H∞ 
framework to treat the model uncertainty on a slightly extended version of metabolic 
equations of glucose and insulin in Fischer and Teo (1989). Parker et al. (2000) too 
employed the H∞ framework to explicitly treat the model uncertainty but they 
employed a detailed and fairly complex physiological patient model (a 19-state 
nonlinear dynamic model) because it allows uncertainty characterization on particular 
tissues or effects that are responsible for the insulin or glucose variability. They 
assessed the resulting H∞ controller based on the disturbance rejection capability on 
577 patients by considering the parametric uncertainty, and concluded that it has 
comparable performance to the computationally-intensive MPC.  
 
Recently, Ruiz-Velazquez et al. (2004) have addressed blood glucose control for 
diabetics as a set point tracking problem using H∞ controller strategy. In this study, 
blood glucose regulation problem was reformulated as a tracking problem. The 
amount of insulin to be injected was specified by H∞ controller strategy to track the 
glucose profile of the healthy patient subjected to meal disturbances. Even though 
maximum tracking error for nominal and worst case condition reported are 15 mg/dl, 
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there is a possibility for prevalence of hyperglycaemia for quite some time, which 
could result in retinopathy and nephropathy over a long run. 
 
1.4 Motivation and Scope of this Work 
The reason why diabetes mellitus is of such concern is that, on a worldwide scale, it 
was estimated that the disease affected 4% of all adults in 1995 and is expected to rise 
to 5.4% by 2025. Compared to other parts of the world, Singapore has a higher 
prevalence rate, with 9% of Singaporeans being diabetic in 1998. In 1999, it 
accounted for 2.2% of annual total mortality in Singapore, and is the sixth most 
common cause of death (Wee et al., 2002).  
 
In addition to the significant mortality, diabetes-related morbidities such as diabetic 
retinopathy, neuropathy and cardiovascular disease have also placed a heavy financial 
burden on society. According to American Diabetes Association (2003), the economic 
costs of diabetes in 1997 was estimated to be US$98 billion, with US$44 billion direct 
medical and treatment costs and US$54 billion for indirect costs. The economic costs 
of diabetes have further increased to US$132 billion, with US$90 billion direct 
medical and treatment costs and US$42 billion for indirect costs. In total U.S. health 
expenditure of US$865 billion, US$160 billion was incurred by people with diabetes. 
In addition, the prevalence of diabetes is increasing drastically in all parts of the world. 
A few recent news paper articles describing the increase in the prevalence of diabetes 
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Diabetes prevalence cause for concern, The Hindu - NEW DELHI, 12 March 
2003 
Madras Diabetes Research Foundation (MDRS), has conducted a survey in five major 
cities -- Mumbai, Chennai, Kolkata, Bangalore and Hyderabad -- where samples of 
2,000 people from each city were taken and “glucose tolerance test” (GTT) conducted. 
In the survey, we found that Hyderabad has the maximum number of diabetes patients 
(where 16 per cent of the respondents tested positive) followed by Chennai (13 per 
cent), Bangalore (12 per cent), Kolkata (11 per cent), Delhi (10 per cent) and Mumbai 
(9 per cent), and World Health Organization (WHO) has already declared India as the 
world's “diabetic Capital” WHO estimates an alarming 250 percent increase in 
diabetics in Indians from 19 millions in 1995 to 57 millions by 2025. 
 
Diabetes up by an alarming 40 percent in Oman, Times of Oman, MUSCAT, 5 
June 2003 
Oman has seen nearly 40 per cent increase of diabetics since the last 10 years, top 
experts here told the Times of Oman yesterday. In Oman, those afflicted with diabetes 
has increased from 8.3 per cent in 1991 to 11.6 per cent in 2000, posting almost 40 
per cent increase in the last decade. Worldwide the problem was getting worse. The 
World Health Organization (WHO) estimates that 135 million people in the world 
suffer from diabetes and it is expected to increase by 170 per cent to 300 million in 
2025, mainly in developing countries. In the second survey, conducted in 2000, but 
published recently, the highest prevalence of diabetes was found in males over 80 
years (26.2 per cent) and in females between 60-69 years (28.3 per cent). Diabetes 
mellitus is a global, public health problem and a leading cause of morbidity and 
mortality. Projections for the year 2025 estimate that the global burden of the disease 
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to increase by 122 per cent, affecting around 300 million people worldwide. The 
problem seems to be very acute in developing countries where a 170 per cent surge in 
diabetes mellitus is forecast, compared to 40 per cent in developed countries. 
According to the annual statistical report, patient morbidity for diabetes mellitus has 
risen steadily from 1,528 cases in 1986 to 3,695 in 2000.  
 
Diabetes Carnival in conjunction with World Diabetes Day November 2003, 
Alexandra Hospital, 15 November 2003 
Almost one in 10 Singaporeans has diabetes and may not even know it. In the next 25 
years the number of people in the world with diabetes will double - from 140 to 300 
millions.  
 
Current clinical treatment methods: 
The current treatment method for diabetes is diet therapy and insulin injection therapy 
with physical activity (i.e. exercise). In diet therapy, the patient is asked to take 
prescribed meal pattern. In insulin injection therapy, prescribed insulin doses will be 
given to the patient at regular intervals, all these are “open loop” in nature. Insulin 
injection therapies, with minor changes in the diet and physical activity have failed to 
maintain the glucose concentration within the allowable ranges leading to 
abnormalities (Parker et al. 2001). So there is a need for new treatment methods to 
assist diabetics to maintain their glucose concentration within the allowable ranges. 
For diabetics, continuous monitoring of blood glucose level with user intervention in 
insulin dosage is thought to be an ideal solution. 
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As current clinical treatment methods being “open-loop nature”, it is thought that 
“closed loop” control approaches can result in good glycaemia control over extended 
periods of time, and also mimic the glucose control in healthy persons. Such closed 
loop control strategy consists of three major components – in-vivo sensor for blood 
glucose concentration, a control algorithm to set appropriate insulin dosage based on 
sensor measurement and a suitable insulin delivery device.  
 
Significant improvements in two major components glucose sensing and insulin 
pumps have led the practical feasibility of artificial β-cells in diabetics. The 
developments in sensor technology have resulted in fast (i.e. within 4 min) and 
reliable glucose concentration measurements, approved by Food and Drug 
Administration (FDA) USA. The implantable insulin pumps are developed and are 
able to deliver insulin accurately and safely; these are also approved by FDA. With 
the significant improvements in the sensing, insulin delivery devices, the development 
of control algorithm is vital. 
 
An algorithm to specify the insulin dosage plays a significant role in maintaining the 
glucose concentration within normoglycemic range in presence of daily activities such 
as meal and exercise. The present study is on the development of simple and effective 
controllers to specify the insulin dosage given the blood glucose measurement. Due to 
the cost and complexity involved in testing the control algorithm on a patient, we plan 
to use a compartmental first principles model of a patient. As significant inter- and 
intra patient variability is reported in the literature, the designed controllers are tested 
on a wide range of patient models in order to evaluate their robustness.  
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The specific objectives of the study are: 
¾ Synthesis and evaluation of model based controllers such as IMC and EIMC 
¾ Synthesis and evaluation of fundamental PID controller, comparison of 
various tuning methods of PID for diabetics 
¾ Synthesis and evaluation of nonlinear controller for diabetics using input 
output linearization technique 
 
1.5 Outline of the Thesis  
This work deals the regulation of blood glucose levels in Type I diabetics. Thesis 
consists of modeling and control aspects of diabetics. Chapter 2 deals with the 
modeling issues and Chapters 3-5 deal with the control aspects. Chapter 2 describes 
the modeling of Type I diabetic, dynamics of meal disturbance(s), uncertainty 
characterization followed by development of test bed to assess the designed 
controller(s) performance. Chapter 3 deals with the synthesis and evaluation of model 
based control strategies such as Internal Model Controller (IMC) and Enhanced 
Internal Model Controller (EIMC) in the presence of meal disturbance(s) and 
parametric uncertainty. Chapter 4 discusses the design of fundamental Proportional-
Integral-Derivative (PID) controller for the diabetics with several tuning rules, 
followed by the assessment of the resulting controllers to track the set point in the 
presence of meal disturbance(s) and parametric uncertainty. Chapter 5 deals with the 
synthesis and evaluation of nonlinear controller using Input Output Linearization 
(IOL) technique. Findings of the present work are summarized in Chapter 6 along 




Physiological Modeling of Diabetic 
2.1 Introduction 
Due to the cost and complexity involved in testing the control algorithm on a diabetic 
patient, model of a diabetic is vital. Performance of the control algorithm in the 
regulation of blood glucose levels for a diabetic is dependant on the accuracy of 
diabetic model. Mismatch in the model to patient dynamics is directly proportional to 
the designed controller performance degradation. So model development is a crucial 
step in designing the controller. 
 
Modeling strategies can be divided into three general categories: first-principles based, 
data-driven and hybrid models. First-principles based models are developed by 
considering the mass, energy and momentum balances for the given physical system. 
Data-driven models are developed based on the input-output data. In this modeling 
strategy, an empirical model employs a user-defined functional form and contains 
coefficients which are identified by fitting the input-output data. Hybrid models are 
the combination of both first-principles and data-driven models. In this strategy, the 
functional form of the system is obtained from mass, energy and momentum balances, 
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2.2 Physiological Modeling 
Several models in literature addressed the interaction of glucose-insulin in the human 
body using different modeling strategies, starting from the early modeling work of 
Bolie (1961). Brief review of modeling literature is available in Section 1.2. 
 
2.2.1 Compartmental Model 
In this study, the detailed physiological model of the human glucose-insulin system 
developed by Parker et al. (2000) based on models developed earlier by              
Guyton et al. (1978) and Sorensen (1985), is used. In this model, human body is 
divided into 6 compartments (brain, heart/lungs, gut, liver, kidney, and periphery) as 
depicted in Fig. 2.1. Mass balance equations for both glucose and insulin around each 
compartment are considered. General representation of a compartment (Fig. 2.2) 
includes capillary blood space, interstitial fluid space and intracellular space, 
throughout each of which the glucose/insulin concentration is assumed to be uniform. 
The capillary blood space is fed by arterial blood inflow and drained by venous blood 
outflow. The interstitial fluid space may exchange mass with the capillary blood space 
by diffusion of solute through the capillary wall. The intracellular space may 
exchange mass with the interstitial fluid space through transport of solute across the 
cell membrane. Based on the cell membrane permeability, capillary wall permeability 
each compartment consists of at most two spaces. For modeling glucose and insulin 
dynamics, all compartments are assumed to have only one space; the exceptions are 
brain (for glucose) and periphery (for both glucose and insulin) having two spaces 
(namely, capillary and tissue). 
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 Insulin Infusion 
Gut Liver 
Fig. 2.1. Compartmental diagram of the glucose and insulin systems in a diabetic. The 
arrow indicates the direction of blood circulation.  
 





On Meal Intake  
From Digestive System 
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vGk =  







vGk =  
The metabolic source and sink terms (ΓI mg/min) in the above equations are defined 
by 
70BU =Γ           (2.9) 
10RBCU =Γ                    (2.10) 
20SU =Γ                    (2.11) 
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HLCLC Γ++=Γ                 (2.26) 
0PIR =Γ , as there is no pancreatic insulin release              (2.27) 
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The mass balances for glucose and insulin over 6 compartments along with metabolic 
terms resulted in 19 nonlinear coupled differential equations with eleven describing 
glucose dynamics, seven for insulin dynamics and one for glucagon. This model 
consists of 47 physiological parameters: values of 35 parameters are in Table 2.1, 
those of 8 other parameters in Table 2.2 and the remaining 4 parameters are ГBU = 70; 
ГRBCU = 10; ГSU = 20 and ГPIR = 0. 
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Table 2.1 Values of the Parameter in the Diabetic Model 
C
Bv =3.5 dL Bq =5.9 L/min BT =2.1 min 
T
Bv =4.5 dL   
C
Hv =13.8 dL Hq =43.7 L/min  
C
Sv =11.2 dL Sq =10.1 L/min  
C
Lv =25.1 dL Lq =12.6 L/min  
 
Aq =2.5 L/min  
C
Kv =6.6 dL Kq =10.1 L/min  
C
Pv =10.4 dL Pq =15.1 L/min 
G
PT =5.0 min 
T
Pv =63.0 L   
C
BV =0.265 L BQ =0.45 L/min  
C
HV =0.985 L HQ =3.12 L/min  
C
SV =0.945 L SQ =0.72 L/min  
C
LV =1.14 L     =0.9 L/min LQ  
 
AQ =0.18 L/min  
C
KV =0.505 L KQ =0.72 L/min  
C
PV =0.735 L PQ =1.05 L/min 
I
PT =20 min 
T
PV =6.3 L   
NV =9.93 L PNCF =0.910 L/min FKC =0.3 
 
The diabetic model has two inputs - insulin delivery and meal disturbance, and one 
measured output, namely, blood glucose concentration. Insulin delivery rate, 
represented as deviation from its 22.3 mU/min nominal delivery, is the manipulated 
variable (represented as u ). The meal disturbance had a nominal value of 0 mg/min 
(absorption into blood stream), and its signal denoted as dm . The output variable, Y  
represents the deviation in blood glucose concentration from the nominal value of 
81.1 mg/dl. All these three variables are scaled as mentioned in Parker et al. (2000). 
 
dd m360
1m = , u
125.33
1u = , Y
20
1Y =                  (2.32)   
 21
                                                           Chapter 2: Physiological Modeling of Diabetic 
Here, the disturbance scaling was determined by its maximum value, scaling for the 
manipulated variable, u is based on its expected range and the output scaling by 
maximum allowable deviation in glucose concentration. Note that the measured value, 
Y is the (blood) plasma glucose concentration, obtained by multiplying the arterial 
glucose concentration (3rd state in the model of Parker et al., 2000) by a factor of 
0.925. A few typographical errors in the differential equations provided in Parker et al. 
(2000) are confirmed, corrected and listed in the Appendix A (Parker, 2002). These 
corrected differential equations (2.1 to 2.31) are reported in this Section 2.2.1. 
 
2.2.2 Uncertainty Description 
Uncertainties exist due to the inevitable patient-model mismatch; the uncertainties 
between the actual patient and the model could be translated to variations in the model 
parameters. The glucose and insulin dynamics were found to be the most sensitive to 
variations in the metabolic parameters of liver and periphery. In the patient model, 
glucose metabolism is mathematically described by threshold functions with the 
following structure: 
Гe = Eгe{Aгe-Bгtanh[Cгe(xi + Dгe)]}                                     (2.33) 
The subscript i in equation (2.33) is the state vector element involved in the metabolic 
effect and subscript e denotes specific effects within the model: the effect of glucose 
on hepatic glucose production (EGHGP), the effect of glucose on hepatic glucose 
uptake (EGHGU) or the effect of insulin on peripheral glucose uptake (EIPGU), 







EGHGP −−=Γ               (2.36) 
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EIPGU −+=Γ                       (2.34) 
These correspond to the last bracketed term in equation (2.12), (2.15) and (2.18) 
respectively. 
 
Inter- or intra-patient uncertainty could be classified physiologically as either receptor 
(Dгe parameter) or post-receptor (Eгe parameter) defect, and these two parameters are 
estimated by fitting the actual patient data. Differences in insulin clearance 
(metabolism) between patients also exist and could be modeled as deviations in the 
fraction of clearance (i.e., insulin utilized) by a given compartment such as the 
fraction of hepatic clearance (FHIC or FLC) or the fraction of peripheral insulin 
clearance (FPIC or FPC). This uncertainty formulation essentially focuses on the liver 
(variability in five parameters) and the peripheral (muscle/fat) tissues (variability in 
three parameters) as these are considered to be more relevant to the control study 
(Parker et al., 2000). Nominal values of these 8 parameters are tabulated in Table 2.2. 
 
In the absence of physical data from which to identify ranges for parametric variations, 
Parker et al. (2000) assumed ±40% variability in each parameter to represent a broad 
range of potential patients. The exception was FHIC, which was limited to ±20% to 
guarantee non-negative glucose concentrations. From these eight parameters, sets of 
three parameters were chosen. Each of these three parameters was tested at three 
levels (nominal, low and high) yielding a total of 8C3 × 33 = 1512 “patients”. Patients 
with identical values for all the eight parameters were removed and this resulted in a 
set of 577 unique patients, which are considered as perturbed cases in further 
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discussion. These patients are assumed to capture all the inter- and intra-patient 
variability among Type I diabetics. These 577 unique patients are considered as the 
test bed to assess the controller performance.  
 
Table 2.2. Nominal Values for Uncertain Parameters in Diabetic Patient Model 
EIPGU-EГ = 1.0 EGHGU-EГ = 1.0 EGHGP-E Г = 1.0 
EIPGU-D Г = -5.82113 EGHGU-D Г = -1.48 EGHGP-D Г = -0.4969 
FHIC (FLC) = 0.4 FPIC (FPC) = 0.15  
 
2.3 Realization of Meal Model 
Lehmann and Deutsch (1992) proposed a model to describe absorption rate of glucose 
into gut from meal taken by the diabetics. This model describes gastric emptying of 
carbohydrates as a saturating function, with a maximum rate (Vmaxge) of 360 mg/min 
carbohydrates to describe carbohydrate release from the stomach during intestinal 
adsorption. The shape of the curve is dependent on the carbohydrates ingested by the 
diabetic patient. If carbohydrates ingested by a diabetic is less than a critical value 
Chcrit calculated by equation (2.37), then shape of the gastric emptying function is 
triangular as in Fig. 2.3 (a), Tascge and Tdesge are the rising and falling times of the 
curve as described in equation (2.38). For carbohydrates ingestion greater than or 
equal to Chcrit, the shape of the gastric empting rate is trapezoidal as shown in          
Fig. 2.3 (b), and Tascge and Tdesge have default values of 30 min. In this case, the time 
of plateau Tmaxge is described by equation (2.39). The Tascge and Tdesge values are at 
default values when carbohydrates ingestion is critical, hence Chcrit = 10.8 g. 
Chcrit = [(Tascge + Tdesge) Vmaxge]/2                (2.37) 
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Tascge = Tdesge = Ch / Vmaxge               (2.38) 
Tmaxge = [Ch – ½ Vmaxge * (Tascge + Tdesge)] /Vmaxge             (2.39) 
Using linear interpolation the rate of gastric emptying rate for meals containing 
carbohydrates greater than Chcrit, can therefore be defined, according to the time 
elapsed from the start of the meal, t, as follows: 
Gempt  = (Vmaxge/Tascge) t  for t < Tascge,    
 = Vmaxge;   for  Tascge < t ≤ Tascge+Tmaxge,                         
 = Vmaxge-(Vmaxge/Tdesge)(t-Tascge-Tmaxge)    
for Tascge + Tmaxge  ≤ t < Tmaxge + Tascge + Tdesge and     
 = 0     for other t               (2.40) 
Either triangular or trapezoidal gastric emptying rate function (Gempt) from equation 
(2.40) is followed by the first-order filter to result in Гmeal representing the absorption 




meal +=Γ                   (2.41) 
The absorption rate of glucose into gut compartment of the diabetic model for 10 and 
50 g carbohydrate intake, shown in Fig. 2.4 is obtained by passing the trapezoidal 
gastric emptying rate function (Fig. 2.3) through the first order filter (equation 2.40). 
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Fig 2.3. The gastric emptying rate for carbohydrate ingestions of (a) 10 g and (b) 50 g. 





























Fig. 2.4. The glucose absorption into gut compartment for 10 g (dotted curve) and     
50 g (solid curve) carbohydrate meal ingestion.  
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2.4 Implementation of Diabetic Model 
Diabetic patient model discussed in Sections 2.2 and 2.3 was implemented in 
Simulink 5.1 along with Matlab 6.5. The DEE block in Simulink is used to solve the 
nonlinear coupled differential equations presented in Section 2.2. The DEE block 
requires the user to provide information such as name, number of inputs, first order 
differential equations in the form of f(x,u), initial guesses (x0), output equations in the 
form of f(x,u). The inputs to and outputs from DEE should be given as vectors u and x 
respectively. The input signals to DEE are numbered as u(1), u(2), u(3) etc in top to 
down order, and outputs are according to the output equations in top to down order. 
The equations in Section 2.2 with all the parameters are coded in the required notation 
for DEE with initial guesses and output equations, to simulate a diabetic. The external 
inputs such as glucose absorption from meal and insulin injection are also present as 
inputs to DEE, so that it becomes easier for the user to study the open loop dynamics 
as well as closed loop dynamics with different control strategies. 
 
The absorption of glucose to gut compartment from carbohydrate ingestion through 
meal was discussed in Section 2.3, and was implemented in Simulink by employing 
Matlab Fcn block, which can be used to run a function in mfile. The Matlab Fcn in 
Simulink gets the input from the Simulink environment and runs the function in mfile 
and the output from the mfile is popped back to Simulink. Thus the diabetic patient 
model is implemented in Simulink as a combination of both DEE block and Matlab 
Fcn block for the meal model. The Simulink implementation of diabetic model with 
DEE, Matlab Fcn and input-output scaling is depicted in Fig. 2.5. 
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Fig. 2.5(a) Simulink implementation of diabetic model with DEE, meal model and 
input-output scaling 
 
Fig 2.5(b) The differential equations editor with diabetic differential equations, initial 
guesses and output equations 
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Fig. 2.5(c). Implementation of the meal model in Simulink using Matlab function 




Fig 2.5(d). The Matlab Fcn block for gastric emptying rate of meal (equation 2.40) 
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Fig. 2.5(e). Input output scaling of insulin and blood plasma glucose concentration 
 
To incorporate the parametric variations, the diabetic model is developed with 
provision to specify the values of parameters. Using this model, 577 patients with 
different parameters can be simulated, and the robustness and disturbance attenuation 
of the designed controllers can be assessed.  
 
Bounds on open-loop responses of some patient models to a step change in insulin 
(from the value required to maintain the output at 81.1 mg/dl) to 0 mU/min, are 
shown in Fig 2.6. These responses are very similar to those reported in Parker (1999), 
confirming the validity of patient models employed in this study. They also show the 
broad range of patient dynamics. Note that glucose profiles shown in Fig. 2.6 are for 
±50% variation in parameters where as only ±40% variation in parameters is 
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Fig. 2.6. Response of some patient models to the step change in insulin to 0 mU/min: 
solid - nominal patient model; dot - response bounds for ± 50% variations in 
EGHGP-EГ; dash-dot - response bounds for the simultaneous ± 50% variations in 
EGHGP-EГ and EIPGU-DГ. 
 
2.5 Dynamics of Diabetic with Meal  
The effect of 10g and 50g carbohydrate ingestion on the glucose absorption into the 
gut is shown in Fig. 2.4. Its subsequent effect on the measured variable, blood plasma 
glucose concentration in the nominal patient model is depicted in Fig. 2.7. The 
important regions based on glucose concentration range for a diabetic are 
hyperglycaemia (> 120 mg/dl), normoglycaemia (70-100 mg/dl) and hypoglycaemia 
(< 60 mg/dl). These and the long term complications associated with the sustained 
prevalence of glucose concentration in these different regions are shown in Fig. 2.7. 
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Normoglycemic Region 
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Fig. 2.7. Transient response of blood plasma glucose concentration due to 50 g (solid 
curve) and 10 g carbohydrate (dashed curve) meal ingestion. 
 
2.6 Summary 
Developing the plant/process models from either white-box (fundamental) or black-
box models ignorant of process physics is challenging. Both of these have their own 
advantages and disadvantages. A diabetic model using physiological compartmental 
division of body with 19 nonlinear coupled differential equations is described. To 
incorporate the inter and intra-patient variability, deviations in patient models are 
limited to 8 parameters only. A test bed of 577 perturbed patients with ±40% 
variations in parameters from the nominal parameter values is generated for assessing 
the controller performance. As the glucose concentration rises upon intake of 
carbohydrate meal, a meal model is also presented. Simulink implementation of 
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diabetic and meal model is discussed. The effect of meal on glucose concentration in 
both gut compartment and measured blood plasma glucose concentration is studied 




Model Based Control Strategies for Glucose Regulation in  
Type I diabetics 
3.1 Introduction 
 
Diabetes mellitus is a global, public health problem and a leading cause of morbidity 
and mortality in many parts of the world. In Type I diabetic or insulin dependent 
diabetes mellitus (IDDM) patient the glucose concentration is elevated beyond the 
normoglycemic range (70-100 mg/dl) due to the insufficient insulin secretion from the 
β-cells of islets of Langerhans present in the pancreas. Sustained hyperglycemia 
(arterial glucose concentration > 120 mg/dl) leads to long-term complications such as 
nephropathy and retinopathy. The current treatment methods (e.g., injections at 
regular intervals) of insulin therapy are largely “open loop”. Intuitively, it can be said 
that “closed loop” control approaches can result in good glycaemia control over 
extended periods of time, and also mimic the glucose control in healthy persons. Such 
closed loop control strategy consists of three major components – in-vivo sensor for 
blood glucose concentration, a control algorithm to set appropriate insulin dosage 
based on sensor measurement and a suitable insulin delivery device. The present work 
focuses on the control algorithm for blood glucose regulation.  
 
For evaluating various controllers, an accurate model of a diabetic patient is essential. 
The primitive modeling studies of the diabetic condition (Bolie 1961,                      
Ackerman et al., 1965) established a precedent for mathematical analysis of           
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insulin-glucose interactions. Later studies utilized the more complicated nonlinear 
models such as Bergman’s “Minimal Model” (Bergman et al., 1981) and incorporated 
physiological system knowledge into the model (Cobelli and Mari, 1983,        
Sorensen, 1985). With the availability of these models, various model-based optimal 
control algorithms have been developed utilizing them in either an explicit or implicit 
fashion (Sorensen, 1985; Ollerton, 1989; Fischer, 1991; Parker et al., 1999). Sorensen 
(1995) also tested an IMC strategy on his model for a particular set of patient 
parameters. Parker et al. (1999) have done an extensive study on blood glucose 
control and compared the performance of several model predictive controllers (MPC) 
as well as a discrete IMC. Camelia and Doyle (2001) used IMC framework to 
maintain the blood glucose concentration in diabetics simulated by Bergman and 
Automatic Insulin Dosage Advisor (AIDA) models. In the synthesis and/or evaluation 
of these controllers, however, the inherent uncertainty in the model has not been 
properly addressed. Such control strategies could lead to significant performance 
degradation in the presence of inevitable patient-model mismatch.  
 
Significant inter- and intra-patient variability has been documented in the literature 
(Simon et al., 1987; Steil et al., 1994; Puckett and Lightfoot, 1995; Bremer and 
Gough, 1999). The control algorithm employed for blood glucose control must be 
able to compensate for the uncertainty that exists between the model used in 
controller design and the actual patient. This clearly brings forth a need for a 
controller that can handle the patient-model mismatch. Keinitz and Yoneyama (1993) 
used the H∞ framework to treat the model uncertainty on a slightly extended version 
of metabolic equations of glucose and insulin in Fischer and Teo (1989).                     
Parker et al. (2000) too employed the H∞ framework to explicitly treat the model 
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uncertainty but they employed a detailed and fairly complex physiological patient 
model (a 19-state nonlinear dynamic model) because it allows uncertainty 
characterization on particular tissues or effects that are responsible for the insulin or 
glucose variability. Parker et al. (2000) assessed the resulting H∞ controller based on 
the disturbance rejection capability on 577 patients by considering the parametric 
uncertainty, and concluded that it has comparable performance to the 
computationally-intensive MPC.  
 
Simple and effective controllers are very desirable for complex applications including 
blood glucose control. IMC and IMC-based tuning are gaining popularity in the 
control community. Further, enhanced IMC (EIMC) of Zhu et al. (1995) has better 
uncertainty and disturbance attenuation in addition to its simple structure. A similar 
structure was proposed for nonlinear processes and experimentally evaluated for pH 
control (Hu et al., 2000). However, neither IMC nor EIMC has been applied for blood 
glucose control of patients simulated by the detailed, physiological model of Parker et 
al. (2000). Motivated by these, the present study has the broad objective of designing 
and evaluating IMC and EIMC for blood glucose control of many diabetics with 
typical inter- and intra-patient variability and simulated by the detailed model of 
Parker et al. (2000). Both single meal and multiple meals in a day are considered as 
disturbances for glucose control of about 580 perturbed patient models. Typical 
responses and quantitative results are presented and discussed.  
 
3.2 Diabetic Model and Uncertainty Description 
A nonlinear pharmacokinetic/pharmacodynamic compartmental model of the diabetic 
patient has been constructed previously (Guyton et al., 1978; Sorensen, 1985;     
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Parker, 1999; Parker et al., 2000). The meal disturbance model of Lehmann and 
Deutsch (1992) was included in the model of Parker et al. (2000), who reported all the 
model equations and parameters in detail with 19 state equations, and 47 parameters. 
The specific operating conditions for the diabetic patient model used in testing the 
robust controller algorithms are described in Parker (1999). The diabetic patient 
model had two inputs - insulin delivery and meal disturbance, and one measured 
output, namely, blood glucose concentration. Insulin delivery rate, represented as 
deviation from its 22.3 mU/min nominal delivery, was the manipulated variable 
(represented as u ). The meal disturbance had a nominal value of 0 mg/min 
(absorption into blood stream), and its signal was denoted as dm . The measured 
variable, Y  represented the deviation in blood glucose concentration from the 
nominal value of 81.1 mg/dl. All these three variables are scaled as mentioned in 
Parker et al. (2000). 
dd m360
1m = , u
125.33
1u = , Y
20
1Y =        (3.1)   
Here, the disturbance scaling was determined by its maximum value, scaling for the 
manipulated variable, u is based on its expected range, and the output scaling by 
maximum allowable deviation in glucose concentration. Note that the measured value, 
Y is (blood) plasma glucose concentration, obtained by multiplying the arterial 
glucose concentration (3rd state in the model of Parker et al., 2000) by a factor of 
0.925. 
 
Uncertainties exist due to the inevitable patient-model mismatch; the uncertainties 
between the actual patient and the nominal patient model could be translated to 
variations in the model parameters. The glucose and insulin dynamics were found to 
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be most sensitive to variations in the metabolic parameters (Parker et al. 1998). In the 
patient model, glucose metabolism is mathematically described by threshold functions 
 th following structure 
more relevant to the control study (Parker et al., 2000).
with e 
         Гe = Eгe{Aгe-Bгtanh[Cгe(xi+Dгe)]                              (3.2) 
The subscript i in equation (3.2) is the state vector element involved in the metabolic 
effect and the e subscript denotes specific effects within the model: the effect of 
glucose on hepatic glucose production (EGHGP), the effect of glucose on hepatic 
glucose uptake (EGHGU) or the effect of insulin on peripheral glucose uptake 
(EIPGU). Inter- or intra-patient uncertainty could be classified physiologically as 
either receptor (Dгe parameter) or post-receptor (Eгe parameter) defect, and these two 
parameters are estimated to fit the actual patient data. Differences in insulin clearance 
(metabolism) between patients also exist, and could be modeled as deviations in the 
fraction of clearance (i.e., insulin utilized) by a given compartment such as the 
fraction of hepatic clearance (FHIC) or the fraction of peripheral insulin clearance 
(FPIC). This uncertainty formulation essentially focused on the liver (variability in 
five parameters) and the peripheral (muscle/fat) tissues (variability in three parameters) 
as these were considered to be 
     
In the absence of physical data from which to identify ranges for parametric variations, 
Parker et al. (2000) assumed ±40% variability in each parameter to represent a broad 
range of potential patients. The exception was FHIC, which was limited to ±20% to 
guarantee non-negative glucose concentrations. From these eight parameters, sets of 
three parameters were chosen. Each of these three parameters was tested at three 
levels (nominal, low and high) yielding a total of 8C3 × 33 = 1512 “patients”. Patients 
with identical values for all the eight parameters were removed and this resulted in a 
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set of 577 unique patients. These 577 unique patients are considered as perturbed 
cases in further discussion. These patients are assumed to capture all the inter- and 
intra-patient variability among Type I diabetics. Each of these patients was subjected 
to a 50 g meal disturbance at time t = 0 under closed-loop to  thtest e robustness and 
isturbance attenuating capabilities of the controller designed.  
to 0 mU/min, are shown in Fig 3.1. These responses are very similar to those reported  
d
 
For the present study, diabetic patient models are developed in Simulink and are 
available from the authors. Bounds on open-loop responses of some patient models to 
a step change in insulin (from the value required to maintain the output at 81.1 mg/dl) 



































. 3.1. Response of some patient models to the step change in insulin to 0 mU/min: 
solid - nominal patient model; dot - response bounds for ± 50% variations in 
EGHGP-E
Fig
onse bounds for the simultaneous ± 50% variations in 
EGHGP-EГ and EIPGU-DГ 
Г; dash-dot - resp
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. 3.2. Response of nonlinear (solid), 19Fig
elay (dot) models to ±5% step changes in insulin from 
the nominal 22.3 mU/min. 
hereas only ±40% variation 
 parameters is considered to test controller robustness. 
th order linear (cross), 3rd order linear (dash-
dot), first order plus time d
 
in Parker (1999), confirming the validity of patient models employed in this study. 
They also show the broad range of patient dynamics. Note that the glucose profiles 
shown in Fig. 3.1 are for ±50% variation in parameters w
in
 
The synthesis of IMC and EIMC controllers requires a linear model of the system to 
be controlled. A 19th order linear model was obtained by linearizing the nonlinear 
model of the nominal diabetic around the nominal plasma glucose concentration of 
81.1 mg/dl. Subsequently, the 19th order linear model was reduced to a 3rd order 
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model using the balanced realization technique. The patient model was also subjected 
to ±5% step change in the manipulated variable (i.e. insulin) and the resulting step 
response was used to identify a first order plus time delay (FOPTD) model using the 
method of Sundaresan and Krishnaswamy (1977). From the step responses of the 
above-mentioned models (Fig 3.2), it appears that a better fit of the patient dynamics 




external disturbance. The IMC controller design involves two steps (Marlin, 1995). 
c
3.3 Synthesis of IMC and EIMC  
The conventional IMC structure is shown in Fig 3.3, where Gp is the plant/patient to 
be controlled, Gm is a model of the plant/patient, C is the IMC controller, R is the 
reference input to the control system, Y is the system output and D is the equivale
 
Fig. 3.3. Conventional IMC system  
Step1: The model, Gm(s) is fa
 
ctorized as  
Gm(s) = Gm+(s) Gm-(s)                                                (3.3) 
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where Gm+(s) contains any time delays and right-half plane zeros. It is specified so 
, Gm-(s) contains t
of Gm(s). 
                                                      
that its steady-state gain is 1. And he remaining invertible dynamics 





−=                                               (3.4) 
where f (s) is a low-pass filter with a steady-state gain of 1. This filter typically has 




where λ is the tuning parameter to be selected by the control engineer so as to meet 
the robustness and performan
)s(f =                                            (3.5) 
ce requirements of the control system. The parameter ‘r’ 
 a positive integer that is selected so that either C(s) is a proper transfer function or 
From Fig 3.3, the closed loop servo transfer function 
GD of the conventional IMC
−−−
IMC compensator and K is pure gain. By inserting this additional path into the 
is
the order of its numerator exceeds the order of the denominator by 1, if ideal 
derivative action is allowed. 
 
GR and the closed loop 




1R ]G)GC(I[G −+=                                    (3.6) 
     11m
1
P
D ])GC(GI[G −−− −+=                                     (3.7) 
The EIMC structure (Zhu et al., 1995), shown in Fig 3.4, has an additional path 
appended to the IMC system within the plant-model parallel structure. Here, in 
addition to the IMC controller, C
1
1 (same as C in Fig. 3.3), C2 is the ‘complementary’ 
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original IMC system, a complementary control signal generated from the plant-model 
error is injected into the output of the original IMC controller. This leads to the EIMC  
 
Fig. 3.4. Enhanced IMC structure 
 
structure whose performance was shown to be superior to IMC in the presence of 
From Fig 3.4, the closed loop servo transfer function  the closed 
disturbance transfer function (G1D) of the EIMC structure can be derived as f low
                  (3.8) 
  (3.9) 
here
modeling errors (Zhu et al., 1995). 
 




























−− ++= . The disturbance attenuating capability of 
the EIMC is improved with large K and a smaller λ
2r1 )s(f,)s(f ==  
nator in the 
quation (3.9) becomes high. The values of r1 and r2 are identical and equal to 1, and 
for simplicity both λ1 and λ2 are taken as equal to λ in the present study.  
 
2 as the denomi
e
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3.4 Results and Discussion 
Based on the FOPTD approximation of the nominal diabetic model, IMC controller 
was first developed for the regulation of glucose level in diabetics. The performance 
of the IMC with various values of filter constant λ was first tested by subjecting the 
nominal patient to 50 g meal disturbance. Robustness of the IMC was then tested on 
all 577 patients and the results are summarized in Table 3.1. The number of patients, 
whose blood glucose concentration was maintained by the IMC within 
normoglycemic range (70-100 mg/dl), is given in the second column. Glucose 
concentration below 60 mg/dl is the dangerous hypoglycemic region. Hence, the 
number of patients whose glucose concentration was maintained by the IMC within 
60-100 mg/dl is also presented in Table 3.1. In addition to these, average IAE and 
standard deviation of IAE based on all 577 patients are also reported in this table. 
Results in Table 3.1 show that decreasing λ has increased number of patients whose 
glucose concentration is maintained between 70-100 mg/dl and 60-100 mg/dl while 
rejecting 50 g meal disturbance, and also the average IAE and standard deviation of 
IAE decreased. These and transient responses (not shown here) indicate that 
decreasing λ has improved the performance of IMC. Even with λ = 2, IMC is not able 
to maintain the glucose concentration within normoglycemic range in 46% of the 
patients. Decreasing λ further to 0.5 and 0.2 (not tabulated here) has resulted in 
sustained oscillations or unstable responses in some perturbed cases. Note that λ = 2 
did not produce sustained oscillations or unstable responses in any of 577 cases. This 
led us to investigate if the EIMC strategy can deliver better disturbance rejection even 
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Table 3.1: Performance of IMC with various values of filter constant, for all 577 
patients subjected to 50 g meal disturbance at time t = 0. 
No. of Patients with Glucose 
Concentration (mg/dl) λ 
70-100 60-100 
Average 





25 113 198 318.9 185.9 
15 163 294 262.5 170.4 
5 251 412 193.5 145.5 
2 310 451 169.4 134.7 
 
Note: In this and subsequent tables, IAE values are for simulation time of 800 min for 
each patient, and the IAE is calculated based on the scaled variable in equation (3.1). 
 
Table 3.1 shows that the number of patients whose glucose concentration is 
maintained in 60-100 mg/dl range, average IAE and standard deviation of IAE do not 
improve significantly when λ is changed from 5 to 2. So, a filter constant of either 2 
or 5 can be used in the EIMC structure. First, λ (= λ1 = λ2) = 2 is employed in the 
EIMC structure and the robustness of EIMC with various K values in EIMC structure 
in rejecting the 50 g meal disturbance in 577 patients is studied. For some patients, the 
injected insulin is negative which is unrealistic and so a saturation block is placed for 
the insulin with a minimum value of 0 mU/min. The EIMC with λ = 2 and a small K 
of 0.5 has decreased the average IAE (125.8) and standard deviation of IAE (111.25) 
than that of IMC with filter constant of 2, but EIMC resulted in sustained oscillations 
or unstable responses in nearly 2% of perturbed patient cases of the study. A higher  
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Table 3.2. Effect of K on rejecting the 50 g meal disturbance by the EIMC (with λ1 = 
λ2 = 5) for all 577 patients with lower limit of 0 mU/min on insulin. 











0 251  412 193.5 145.5 
1 423 499 116.8 105.8 
2 478 513 84.5 82.8 
3 481 537 66.3 67.8 
4 488 551 54.6 57.3 
5 490 567 46.8 49.3 
 
value of K along with λ = 2 has further increased the number of patients with 
sustained oscillations and unstable responses. Hence, λ = 5 is selected for studying the 
robustness of EIMC with various K values and the results are tabulated in Table 3.2. 
  
From Table 3.2, increasing the K value has resulted in significant improvement in the 
glucose control with increase in the number of patients whose glucose concentration 
is maintained within 70-100 mg/dl and 60-100 mg/dl ranges, and decrease in average 
IAE and standard deviation of IAE. The improvement in the number of patients 
controlled within the allowable ranges by increasing the K value from 3 is not 
significant and also the higher value of K resulted in sustained oscillations or unstable 
responses for some perturbed cases. One of such responses for a perturbed case with 
parameters EGHGP-EГ = 1.4; EIPGU-DГ = -3.4927; EGHGU-DГ = -0.88; and rest of  
 46
                              Chapter 3: Model Based Control Strategies for Glucose Regulation 










































Fig. 3.5. The effect of increasing K in EIMC for a perturbed case with                 
EGHGP-EГ =1.4, EIPGU-DГ = -3.4927 and EGHGU-DГ = -0.88 with remaining 
parameters at their nominal values. 
 
the parameters at their nominal values, is shown in Fig. 3.5. For K = 4, blood glucose 
and insulin have steadily growing oscillations while K = 5 has resulted in sustained 
oscillations due to the lower limit of 0 mU/min on insulin. The response of EIMC 
with K = 3 is acceptable. Hence, from Fig. 3.5 and Table 3.3, K = 3 seems to be 
‘optimal’ and the parameter values: λ1 = 5, λ2 = 5 and K = 3 are employed in the 
EIMC in the subsequent discussion. For these parameter values, only 40 patients (7%) 
have entered the dangerous hypoglycemic region (i.e. glucose concentration < 60 
mg/dl). This is better than 72 patients mentioned by Parker et al. (2000) when H∞ 
controller was employed. It is interesting to note that one parameter, namely, FPIC is 
at 0.21 (a +40% variation from nominal) in the 40 perturbed patients which could not 
be controlled safely by the EIMC. 
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Fig. 3.6. Transient responses of the EIMC for two perturbed patients (giving the 
lowest and highest IAE) and the nominal case, in attenuating 50 g meal 
disturbance at time t = 0 min. 
 
Performance of the EIMC on two perturbed patients and nominal patient is depicted 
in Fig 3.6. The two perturbed patients considered are those having the lowest and 
highest IAE value among the 537 patients whose glucose concentration was 
controlled within 60-100 mg/dl. The parameters of the patient with the lowest IAE are 
EGHGU-DГ = -0.88; FHIC = 0.32; FPIC = 0.09, while those of the patient with the 
highest IAE are EGHGP-DГ = -0.29814; FHIC = 0.48; FPIC = 0.21. The rest of the 
parameters are at their nominal values for both cases. Transient profiles of blood 
glucose and insulin in Fig. 3.6 are very good with very few oscillations. 
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Next, the EIMC controller is tested on two patient cases whose disturbance rejection 
responses by H∞ controller are given in Parker et al. (2000). Parameters for the first 
patient case are different from the 577 patients considered above. The parameters of 
this case are EIPGU-DГ = -8.15; EGHGU-DГ = -2.072; FHIC = 0.36; rest of the 
parameters are at their nominal values. This case is specified as the worst-case 
performance of the continuous-time H∞ controller, including uncertainty weighting 
and parametric uncertainty (Parker et al., 2000). Disturbance rejection by the H∞ 
controller for this case shown in Figure 9 of Parker et al. (2000) is reproduced along 
with the response by the EIMC in Fig 3.7. Parameters for the second patient case are  


































Fig. 3.7. Performance of EIMC (solid) and H∞ controller (dashed) of Parker et al. 
(2000) including uncertainty weighting and parametric uncertainty, on a perturbed 
patient model with EIPGU-DГ = -8.15, EGHGU-DГ = -2.072, FHIC = 0.36 and the 
remaining five parameters are at their nominal values. 
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EIPGU-EГ = 0.6; EGHGU-EГ = 0.6; EGHGP-EГ = 1.4; remaining parameters are 
retained at their nominal values. The responses by the EIMC and H∞ controller of 
Parker et al. (2000) for this patient model are depicted in Fig 3.8. These and those in 
Fig. 3.7 show that the performance of EIMC compares very favorably and performs 
even better than the results provided by the H∞ strategy of Parker et al. (2000). 

































Fig. 3.8. Performance of EIMC (solid) and H∞ controller (dashed) of                        
Parker et al. (2000) including uncertainty weighting and parametric uncertainty, 
on a perturbed patient model with EIPGU-EГ = 0.6, EGHGU-EГ = 0.6,            
EGHGP-EГ = 1.4 and the remaining five parameters are at their nominal values. 
 
The performance of EIMC with parameters λ1 = λ2 = 5 and K = 3, in rejecting the 
typical meal pattern for a day from 7.30 a.m. for 24 hours for all 577 patients, is then 
studied. The typical meal pattern is assumed to have 50 g, 30 g, 50 g and 10 g of 
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carbohydrates respectively in the breakfast, lunch, dinner and supper at the following 
times: breakfast at 7:30 a.m, lunch at 12:30 p.m., dinner at 6:00 p.m. and supper at 
9:00 p.m. The EIMC controller is able to maintain the glucose concentration within 
60-100 mg/dl range for all the four meal disturbances in 93 % of the 577 patients 
tested, which are the same as those of the single meal case (Table 3.2). The average 
IAE and the standard deviation of IAE for this situation of four meals are increased by 
a factor compared to that of the single meal case. The responses of the patients to four 
meals for the highest IAE patient case, nominal patient case and the lowest IAE case 
within the 537 patient cases are shown in Fig. 3.9. These results confirm the 
effectiveness of the EIMC for blood glucose control of diabetics. 
 








































Fig. 3.9. Transient responses of the EIMC for two perturbed patients (giving the 
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3.5 Conclusions 
The IMC and EIMC are designed using a simple FOPTD model of the nominal 
patient and their robustness is evaluated for regulation of blood glucose concentration 
in 577 diabetics obtained by considering ±40% parametric variations from the 
nominal patient parameter values. The EIMC is able to maintain the glucose 
concentration above the dangerous hypoglycemic range (< 60 mg/dl) in 93% of 577 
patient models tested. For these patients, average IAE and standard deviation of IAE 
are reduced by a factor of 2 to 3 by the EIMC scheme compared to the conventional 
IMC. Further, the performance of the former is found to be better than that of a H∞ 
controller proposed by Parker et al. (2000). The EIMC is tested on all 577 patients 
taking four meals per day and the controller is able to maintain the glucose 
concentration above the dangerous hypoglycemic range in 93% of the cases (same 
number of cases as for the single meal). Thus, the EIMC strategy is very attractive for 






Regulation of Glucose in Diabetics using PID controller 
4.1 Introduction 
 
Type I diabetes or insulin dependant diabetes mellitus (IDDM) is an endocrine 
carbohydrate metabolic disorder in which blood sugar is increased from the normal 
70-100 mg/dl due to the insufficient secretion of insulin by the β-cells of islets of 
langerhans present in the pancreas. Significant mortality, diabetes-related morbidities 
such as diabetic retinopathy, neuropathy and cardiovascular disease have also placed a 
heavy financial burden on society. The economic cost of diabetes in total U.S. health 
expenditure of US$865 billions was estimated at US$132 billions (in year 2002) by 
the American Diabetes Association, with US$92 billions spent on direct medical and 
treatment costs and US$40 billions incurred as indirect costs such as lost work time, 
disability and premature mortality (American Diabetes Association, 2003). As current 
clinical treatment methods are “open loop” in nature, it is thought that “closed loop” 
control approaches can result in good glycaemia control over extended periods of time, 
and also mimic the glucose control in healthy persons.  
 
This “closed loop” control requires a closed loop device comprising three components, 
a mechanical pump, in-vivo glucose sensor and a control algorithm to specify the 
insulin dosage based on sensor measurement. Significant improvements in glucose 
sensing and insulin pumps have led to the practical feasibility of closed loop 
regulatory systems (often referred to as "artificial" β-cells) for blood glucose 
regulation in diabetics. The developments in glucose sensor technology have resulted 
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in fast (i.e. within 4 min) and reliable glucose concentration measurements        
(Renard, 2002). This sensor has been approved by the Food and Drug Administration 
(FDA), USA. The implantable insulin pumps able to deliver insulin accurately and 
safely are developed and are also approved by the FDA. To complement these 
improvements in the sensing and insulin delivery devices, the development of an 
effective control algorithm is vital. Due to the cost and complexity involved in 
clinically testing control algorithms, studies are done using a suitable model of 
diabetic patients. 
 
A good review of diabetic modeling studies can be found in Parker (1999). In the 
present study, the detailed physiological model of the human glucose-insulin system 
described in Parker et al. (2000) is used. This model is based on models developed 
earlier by Guyton et al. (1978) and Sorensen (1985). Parker et al. (2001) reviewed the 
open loop, semi-closed loop and closed loop control efforts concerning the blood 
glucose regulation in diabetics. Proportional Derivative (PD) and Proportional 
Integral (PI) type controllers (belonging to the Proportional-Integral-Derivative (PID) 
controller family) are employed for blood glucose control by Fischer et al. (1990) and 
Chee et al. (2003) respectively. Even though a significant number of model-based 
control strategies have been proposed and assessed, the fundamental PID controller is 
not developed for the detailed physiological model of Parker et al. (2000) and studied 
for its robustness to parametric uncertainties.  
 
Despite the significant improvements made in control theory and in the control of 
complex processes, the PID controller continues to be the workhorse for regulatory 
control in the chemical and process industries. Its simple structure, accumulated 
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experience in its design and its effectiveness on a wide range of industrial processes 
make it extremely attractive for biomedical applications as well. Therefore, in the 
present study, the PID controller is designed for the model described in                
Parker et al. (2000), using both the classical and the recent tuning methods. The PID 
controller is tuned with IAE minimization (for disturbance rejection) as the objective, 
Cohen-Coon tuning and two recently developed tuning methods, namely, Shen (2002) 
method and DMC-based method of Haeri (2002). The resulting PID controllers are 
assessed for their ability to track normoglycemic set point in a diabetic while 
subjected to a 50 g meal disturbance. Their robustness is tested on a population of 577 
patient models which are obtained by considering ±40% uncertainty in the model 
parameters. Both single meal and multiple meals (in a day) scenarios are considered 
as disturbances for blood glucose control. Quantitative results and typical responses 
are presented and discussed. 
 
4.2 Diabetic Model and Uncertainty Description 
The following diabetic model and uncertainty description is also available in               
section 3.2. To provide better readability to each chapter independently we included 
this section. A nonlinear pharmacokinetic/pharmacodynamic compartmental model of 
the diabetic patient has been constructed previously (Guyton et al., 1978; Sorensen, 
1985; Parker, 1999). The meal disturbance model of Lehmann and Deutsch (1992) 
was included in the model of Parker et al. (2000) who reported all the model 
equations and parameters in detail. This model has 19 state equations (nonlinear, 
coupled ordinary differential equations) and uses 47 physiological parameters. The 
diabetic patient model has been constructed to represent the sedentary 70 kg male 
patient (Parker, 1999), and has two inputs - insulin delivery and meal disturbance, and 
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one measured output - blood glucose concentration. Insulin delivery rate, represented 
as a deviation from its 22.3 mU/min nominal delivery is the manipulated variable 
(represented as u ). The meal disturbance has a nominal value of 0 mg/min 
(absorption into blood stream), and its signal is denoted as dm . The measured 
variable, Y  represents the deviation in blood glucose concentration from the nominal 
value of 81.1 mg/dl. All these three variables are scaled as mentioned in                        
Parker et al. (2000). 
dd m360
1m = , u
125.33
1u = , Y
20
1Y =        (4.1)   
Here, the disturbance scaling is determined by its maximum value, scaling for the 
manipulated variable, u is based on its expected range, and the output scaling by the 
maximum allowable deviation in glucose concentration. Note that the measured value, 
Y is the scaled plasma glucose deviation variable, obtained by multiplying the arterial 
glucose concentration (third state in the model of Parker et al., 2000) by a             
factor of 0.925. 
 
Uncertainties exist due to the inevitable patient-model mismatch; the uncertainties 
between the actual patient and the nominal patient model could be translated to 
variations in the model parameters. The glucose and insulin dynamics were found to 
be the most sensitive to variations in the metabolic parameters of liver and periphery. 
In the patient model, glucose metabolism is mathematically described by threshold 
functions with the following structure: 
Гe = Eгe{Aгe-Bгtanh[Cгe(xi+Dгe)]}                                     (4.2) 
The subscript i in equation (4.2) is the state vector element involved in the metabolic 
effect and subscript e denotes specific effects within the model: the effect of glucose 
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on hepatic glucose production (EGHGP), the effect of glucose on hepatic glucose 
uptake (EGHGU) or the effect of insulin on peripheral glucose uptake (EIPGU).  
Inter- or intra-patient uncertainty could be classified physiologically as either receptor  
(D
    
  these are 
e more relevant to the control study (Parker et al., 2000).  
 t st the robustness and disturbance 
ttenuating capabilities of the designed controller.  
 
гe parameter) or post-receptor (Eгe parameter) defect, and these two parameters are 
estimated to fit the actual patient data. Differences in insulin clearance (metabolism) 
between patients also exist and could be modeled as deviations in the fraction of 
clearance (i.e., insulin utilized) by a given compartment such as the fraction of hepatic 
clearance (FHIC) or the fraction of peripheral insulin clearance (FPIC). This 
uncertainty formulation essentially focuses on the liver (variability in five parameters) 
and the peripheral (muscle/fat) tissues (variability in three parameters) as
considered to b
  
In the absence of physical data from which to identify ranges for parametric variations, 
Parker et al. (2000) assumed ±40% variability in each parameter to represent a broad 
range of potential patients. The exception was FHIC, which was limited to ±20% to 
guarantee non-negative glucose concentrations. From these eight parameters, sets of 
three parameters were chosen. Each of these three parameters was tested at three 
levels (nominal, low and high) yielding a total of 8C3 × 33 = 1512 “patients”. Patients 
with identical values for all the eight parameters were removed and this resulted in a 
set of 577 unique patients, which are considered as perturbed cases in further 
discussion. These patients are assumed to capture all the inter- and intra-patient 
variability among Type I diabetics. Each of these patients will be subjected to a 50 g 
meal disturbance at time t = 0 under closed-loop to e
a
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Fig. 4.1. Response of some patient models to the step change in insulin to 0 mU/min: 
solid - nominal patient model; dot - response bounds for ± 50% variations in 
EGHGP-EГ; dash-dot - response bounds for the simultaneous ± 50% variations in 
EGHGP-EГ and EIPGU-DГ. 
 
For the present study, diabetic patient model is developed in Simulink and is available 
from the authors. Bounds on open-loop responses of some patient models to a step 
change in insulin (from the value required to maintain the output at 81.1 mg/dl) to      
0 mU/min, are shown in Fig. 4.1. These responses are very similar to those reported in 
Parker (1999) confirming the validity of patient models employed in this study. They 
also show the broad range of patient dynamics and their nonlinearity. Note that the 
glucose profiles shown in Fig. 4.1 are for ±50% variation in parameters for 
comparison with the profiles in Parker (1999), whereas only ±40% variation in 
parameters is considered to test controller robustness as in Parker et al. (2000). 
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Available tuning methods for PID controller are often based on a first order plus dead 
time (FOPDT) model of the system to be controlled. The nominal patient model was 
subjected to ±5% step change in the manipulated variable (i.e. insulin) and the 
resulting step response for positive step change was used to identify a FOPDT model 
using the method of Sundaresan and Krishnaswamy (1977). The step responses of the 
nominal patient model and FOPDT model are depicted in Fig. 4.2. This FOPDT 
model (with gain = -3.29 (mg/dl)/(mU/min) or -5.46 in units consistent for u and Y in 
equation (1), time constant = 68.3 min and dead time = 12.8 min), is then employed to 
find the PID controller parameters: KP, KI and KD using different tuning methods. 
 


































First order plus time delay
 
Fig. 4.2. Response of nonlinear (solid) and first order plus time delay (dot) models to 
± 5% step changes in insulin from the nominal 22.3 mU/min. 
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4.3 PID Controller Tuning 
The ideal PID controller has the form: 
dt
)t(deKdt)t(eK)t(eK)t(u DIP ∫ ++=    (4.3) 
where u(t) = controller output, e(t) = error = Ysp(t) – Y(t), Ysp(t) = set point = 0 and 
Y(t) is the scaled plasma glucose concentration (expressed as deviation from the 
nominal value). The parameters KP, KI and KD are relative weights of proportional, 
integral and derivative components of the control action respectively. 
 
Ziegler and Nichols (1942) proposed the first set of PID tuning rules. A significant 
number of tuning rules based on Ziegler and Nichols tuning procedure have since 
been developed. These tuning methods can be classified as direct and indirect 
methods. Direct tuning methods do not require a process model - tuning is performed 
in a closed-loop manner. This is a relatively time consuming procedure requiring an 
initially tuned controller and a predefined “desired” closed-loop response             
(Chen and Seborg, 2002). On the other hand, indirect methods are based on the 
process models obtained from a step or frequency response experiment. The quality of 
the controller parameters obtained is dependent on the quality of the identified process 
model. Several tuning rules available in the literature are based on optimizing integral 
performance criteria like IAE, ISE or ITAE and consider either set point tracking, 
disturbance rejection or both (with equal or variable weighting factors). For example, 
Ciancone PID controller tuning correlations (Marlin, 1995) are developed based on 
minimization of the cumulative sum of IAE by considering ±25% variation in the 
process parameters with limits on manipulated variable movement for disturbance 
rejection or set point tracking. Simple PI, PD and PID controller settings for 
 60
                                                 Chapter 4: Regulation of Glucose using PID controller 
integrating plus time delay processes, unstable processes are developed based on 
matching the coefficients of corresponding powers of ‘s’ in the numerator and 
denominator of closed-loop transfer function to a servo problem (Chidambaram and 
Padma Sree, 2003). Shen (2002) has recently developed PID controller tuning 
relations by minimizing the sum of equally weighted IAE due to set point change and 
disturbance, using a genetic algorithm. In view of the increasing popularity of the 
Dynamic Matrix Control (DMC) in the chemical industry, Haeri (2002) has developed 
a tuning method for PID in which the controller parameters are adjusted to have 
performance similar to that of DMC. In this study, PID with IAE minimization (for 
disturbance rejection) tuning, Cohen-Coon tuning and the recently developed Shen 
(2002) tuning and DMC-based method (Haeri, 2002) are used for blood glucose 
control in diabetics. The different PID controllers are assessed based on their ability to 
attenuate a 50 g meal disturbance as well as their robustness to parametric 
uncertainties due to the inevitable patient-model mismatch.  
 
4.4 Results and Discussion 
The FOPDT model is obtained by approximating the step response of the nominal 
diabetic patient. The parameters KP, KI and KD of the PID controller using the 
aforementioned four tuning methods are obtained for this FOPDT model and are 
given in Table 4.1; the relations employed in the four methods are summarized in 
Appendix. The performance of PID by the four tuning methods in rejecting the 50 g 
meal taken by the nominal patient is depicted in Fig. 4.3. The overshoot, undershoot 
and IAE observed in each case are tabulated in Table 4.1. From Fig. 4.3 and Table 4.1, 
it is evident that the performance of PID with Shen method of tuning is better than the 
other three methods, in terms of the highest and lowest glucose concentration  
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Table 4.1. The performance of PID controllers tuned by four methods, on the nominal 
patient case in attenuating the 50 g meal disturbance. 
 









IAE minimization -1.23 -0.055 -6.034 6.98 10.32 46.9 23180 
Cohen-Coon -1.35 -0.046 -6.076 6.95 9.94 49.4 23125 
DMC-based -0.84 -0.007 -6.724 12.67 8.54 158.5 22574 
Shen -3.87 -0.08 -36.5 2.46 2.97 25.8 22987 
 
Note: In this and subsequent tables, IAE values are for a simulation time of 800 min 
for each patient, and the IAE is calculated based on the scaled variable in                
equation (4.1). 
 
Fig. 4.3. Performance of PID controllers tuned by four methods on the nominal 
patient model in rejecting the 50 g meal disturbance at time, t = 0 min. 
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observed in the rejection of the meal disturbance. The IAE by Shen method is almost 
half of the next best method. Even though the PID controller designed with the Shen 
method outperformed other tunings, it is interesting to note that total amount of 
insulin injected in rejecting the 50 g meal is almost the same (Table 4.1). A steep 
insulin delivery profile is seen early on for the PID controller tuned by Shen method 
(Fig. 4.3); this helps in minimizing the deviations observed in the glucose level as 
compared to other controllers. The superiority of the Shen tuning over the other 
tunings including IAE minimization, may be due to the ability of optimization 
algorithm (i.e. Genetic Algorithm) to find the global optimum, use of equally 
weighted IAE due to set point change and disturbance, and/or a more appropriate 
structure of correlations used in developing the tuning relations. 
 
The robustness of the various PID controllers in rejecting the 50 g meal disturbance 
on 577 patients is studied and the results are summarized in Table 4.2. From Table 4.2, 
one can conclude that Shen method of PID tuning outperformed the other three tuning 
methods in terms of the number of patients whose blood glucose concentration 
remains within 70-100 mg/dl and 60-100 mg/dl ranges. The average IAE and standard 
deviation of IAE by the Shen method are two to three times lower than those obtained 
with the other three tuning methods considered here. Therefore, only tuning method 
of Shen (2002) is considered for further discussion. For this PID tuning, only 26 
patients (5% of the patient population) have entered the dangerous hypoglycemic 
region (blood glucose concentration less than 60 mg/dl). This result is better than the 
72 patients who entered the hypoglycemic region in the H∞ controller based blood 
glucose regulation work (Parker et al., 2000) and the 40 patients in the enhanced  
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Table 4.2. The performance of PID controllers tuned by the four methods on the 577 
patients in attenuating the 50 g meal disturbance. 
No. of Patients with 
Glucose Conc. (mg/dl) Tuning 
70-100 60-100 
Average IAE for 




IAE minimization 296 479 76.3 76.8 
Cohen-Coon 327 481 79.5 81.9 
DMC-based 359 426 200.8 148.4 
Shen 488 551 42.7 46.4 
 
internal model control (EIMC) strategy considered by Ramprasad et al. (2004). It is 
interesting to note that one parameter, namely, FPIC is at 0.21 (a +40% variation from  
its nominal value) in the 26 “patients” who could not be controlled safely by using the 
Shen method of PID tuning. Patients with such values of FPIC are perhaps more 
difficult to control using linear feedback control strategies. 
 
The performance of PID with Shen tuning on two perturbed patients and the nominal 
patient is depicted in Fig. 4.4. The two perturbed patients considered had the lowest 
and highest IAE among the 551 patients whose glucose concentration was controlled 
within 60-100 mg/dl. The parameters of the patient with the lowest IAE are         
EGHGU-DГ = -0.88; FHIC = 0.32 and FPIC = 0.09 while those of the patient with the 
highest IAE are EGHGP-EГ = 1.4; EGHGU-DГ = -2.072 and FPIC = 0.21. The rest of 
the parameters are at their nominal values for both cases. Transient profiles of blood 
glucose and insulin in Fig. 4.4 are very good with little or no oscillations. 
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Fig. 4.4. Transient responses of PID controller with Shen tuning for two perturbed 
patients (giving the lowest and highest IAE) and the nominal case, in attenuating 
50 g meal disturbance at time, t = 0 min. 
 
PID controller with Shen tuning is now tested on two patient cases whose disturbance 
rejection responses are given in Parker et al. (2000). The parameters for the first 
patient are different from the 577 patients considered above; they are                 
EIPGU-DГ = -8.15; EGHGU-DГ = -2.072; FHIC = 0.36 and rest of the parameters are 
at their nominal values. This case is specified as the worst-case performance of the 
continuous-time H∞ controller, including uncertainty weighting and parametric 
uncertainty (Parker et al., 2000). Disturbance rejection by the H∞ controller for this 
case shown in Figure 9 of Parker et al. (2000) is reproduced along with the response 
by the PID controller in Fig 4.5. Parameters for the second patient case are        
EIPGU-EГ = 0.6; EGHGU-EГ = 0.6; EGHGP-EГ = 1.4 and the remaining parameters 
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are retained at their nominal values. The responses by the PID controller and H∞ 
controller (Parker et al. 2000) for this patient model are depicted in Fig 4.6. Figures 
4.5 and 4.6 show that the performance of PID controller is very good and better than 
the H∞ strategy of Parker et al. (2000). 
 


































Fig. 4.5. Performance of PID controller with Shen tuning (solid) and H∞ controller 
(dashed) including uncertainty weighting and parametric uncertainty                     
(Parker et al., 2000), on a perturbed patient model with EIPGU-DГ = -8.15; 
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Fig. 4.6. Performance of PID controller with Shen tuning (solid) and H∞ controller 
(dashed) including uncertainty weighting and parametric uncertainty           
(Parker et al., 2000), on a perturbed patient with EIPGU-EГ = 0.6;              
EGHGU-EГ = 0.6, EGHGP-EГ = 1.4 and the remaining five parameters are at their 
nominal values. 
 
The performance of the PID controller with Shen tuning in rejecting the typical meal 
pattern for a 24 hour period (one day) is then studied for all the 577 patients. The 
typical meal pattern is assumed to have 50 g, 30 g, 50 g and 10 g of carbohydrates 
respectively in the breakfast, lunch, dinner and supper at the following times: 
breakfast at 7:30 a.m., lunch at 12:30 p.m., dinner at 6 p.m. and supper at 9 p.m. The 
PID controller tuned by the Shen method is able to maintain the blood glucose 
concentration within 60-100 mg/dl range for all the four meal disturbances in 95% of  
 67
                                                 Chapter 4: Regulation of Glucose using PID controller 









































Fig. 4.7. Transient responses of the PID controller with Shen tuning for two perturbed 
patients (giving the lowest and highest IAE) and the nominal case, in attenuating 
four meals in a typical day. 
 
the 577 patients tested. This is essentially the same as those of the single meal case 
(Table 4.2). The average IAE and the standard deviation of IAE for this situation of 
four meals are increased by a constant factor compared to that of the single meal case. 
The responses of the patients to four meals for three patient cases: having the highest 
IAE, nominal patient and having the lowest IAE patient case (from the well controlled 
551 patient cases) are shown in Fig. 4.7. These results confirm the effectiveness of the 
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Table 4.3. The performance of PID controllers tuned by Shen method but with various 
values of KP on the 577 patients in attenuating the 50 g meal disturbance. 
No. of Patients with 
Glucose Conc. (mg/dl) KP
70-100 60-100 
Average IAE 





-3.87 488 551 42.7 46.4 
-5 496 573 39.0 42.4 
-6  515 577 36.2 39.4 
-7 541 577 33.9 36.8 
 
A careful observation of the PID controller parameters (KP, KI, KD) obtained by the 
four tuning methods investigated here (see Table 4.1) indicates that the proportional 
gain, KP in the Shen method is higher than that obtained by the other three tuning 
methods by a factor of at least 3. From our observations, KP seems to play an 
important role in effectively rejecting the meal disturbance. Hence, the PID controller 
performance with higher values of KP, while keeping the integral action KI (-0.08) and 
derivative action KD (-36.5) as constant, is studied and the results are tabulated in 
Table 3. Interestingly for a KP value of -6, the PID controller is able to maintain the 
glucose concentration above the dangerous hypoglycemic region (< 60 mg/dl) for all 
the 577 patients under study. Further increase of KP to -7 has decreased the average 
IAE and standard deviation of IAE, but resulted in sustained oscillations for some 
patient cases. One such perturbed patient response with three different KP values is 
depicted in Fig. 4.8. The parameters for this perturbed patient are EGHGP-EГ = 1.4;           
FHIC = 0.32 and FPIC = 0.09 with the rest of parameters retained at their nominal  
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Fig. 4.8. Transient response of PID controllers with three different values of KP for a 
perturbed patient with parameters EGHGP-EГ = 1.4, FHIC = 0.32, FPIC = 0.09 
and rest of the parameters are at their nominal values. 
 
values. The average IAE and standard deviation of IAE have decreased by using a 
higher KP of -6 in lieu of -3.87 (Table 4.3), but oscillations and settling time have 
increased slightly (Fig. 4.8). Assuming these are acceptable, KP = -6 is recommended 
in order to achieve better robustness for blood glucose regulation of all patients. 
 
4.5 Conclusions 
The performance and robustness of different PID controllers obtained using four 
tuning methods are investigated for maintaining blood glucose concentration of a 
population of 577 diabetics. Controller parameters have been determined using a 
FOPDT approximation of a detailed first principles physiological model representing 
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a nominal diabetic patient. The Shen tuning method outperformed the other three 
tunings (i.e. IAE minimization for disturbance rejection, Cohen-Coon, DMC-based) 
both in disturbance rejection and robustness characteristics. The PID controller tuned 
by it is able to maintain the glucose concentration above the dangerous hypoglycemic 
range (< 60 mg/dl) in 95% of 577 patient models of the study. The average IAE and 
standard deviation of IAE are reduced by a factor of two by the Shen method than 
IAE minimization tuning for disturbance rejection and Cohen-Coon tuning, whereas 
the reduction is by a factor of about five compared to DMC-based PID tuning. The 
PID controller with Shen method, when tested on all 577 patients considering a 
typical meal pattern of four meals per day, is also able to maintain the glucose 
concentration above the hypoglycemic range in 95% of the cases (same number of 
cases as for the single meal). Further fine tuning of this PID controller is able to 
maintain the glucose concentration above the hypoglycemic range in all the 577 
patients considered. Thus, results of this study show that the PID controller with 
proper tuning is very attractive for blood glucose control owing to its simple structure 







Input Output Linearization for Glucose Regulation 
in Type I Diabetics 
5.1 Introduction  
Nonlinearity in many common processes such as distillation columns, chemical 
reactions and acid base neutralization process is observed. Model based control 
strategies for nonlinear processes have been based on local linearization and a linear 
controller based on the linearized model. For highly nonlinear processes detuning of 
linear feedback controllers is required to ensure their stability, which in turn degrades 
the performance. The development of geometric methods to arrive at exact 
linearization of nonlinear models independent of the operating points (Isidori, 1989) 
allowed designing the linear controllers for the equivalent linear system to meet the 
performance requirements. One such controller synthesis and experimental evaluation 
using Nonlinear Internal Model Controller (NIMC) and Augmented Internal Model 
Controller (AuIMC) for a highly nonlinear neutralization process was discussed by 
Hu et al. (2000). In the present study, the synthesis and evaluation of a nonlinear 
controller with NIMC structure for a diabetic is discussed. 
 
5.2 Synthesis of IOL Controller 





       (5.1) 
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where  is the vector of states, u is the manipulated input, y is the output, f(x) 
and g(x) are smooth vector fields on R
nRx∈
n, and h(x) is a smooth function on Rn.  
 























n1f #               (5.2) 
The following notation is used for repeated Lie Derivatives: . )x(L))x(L(L 2fff λ=λ
 
Similarly for any system described in the form of equation (5.1), the Lie Derivatives 
 are calculated. The relative 
degree of the nonlinear system in equation (5.1) is the smallest integer r for which 
 and in some 
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0. The relative degree of the diabetic 






Fig. 5.1(a) Nonlinear controller with input output linearization 
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Fig. 5.1(b) Nonlinear Internal Model Control (NIMC) Structure 
 







γ−=        (5.3) 





f α+α−−α−α−= −γ−γ−γγ "    (5.4) 
where r is the set-point, and s'α  are the tuning parameters chosen such that the 
closed-loop system is input-output stable. (Fig 5.1 a) 
 
The input-output linearizing controller (i.e. equation 5.3 and 5.4) requires the 
measurement of all the states of the nonlinear system, which is not possible in all the 
cases. So a new controller structure NIMC (Fig. 5.1b) in IMC form is developed. 
Advantages of NIMC are offset-free response and model M acts as open-loop 
observer (Hu and Rangaiah, 1999). 
 
For the process in equation (5.1), assume that the model, M available for the 















       (5.2) 
where x~  is the vector of model states, y~  is the model output, ,  and  
are defined similar to the corresponding functions for the process equation (5.1).  
Thus, tilde on a variable indicates that the quantity refers to the model, which is also 
used in the NIMC controller. 
)x~(f~ )x~(g~ )x~(h~
 
The standard IOL controller system shown in Fig. 5.1(a) (Isidori, 1995), can be put 














f~ α+α−−α−α−= −γ−γ−γγ "   (5.6) 
where .   y~yre +−=
Thus the control law does not require derivatives of the output. Since the relative 
order for the diabetic system is 4, the resulting transfer function between output and 











α=      (5.7) 
The controller in equation (5.6) involves r tuning parameters. As suggested by 
Kravaris and Wright (1989), the transfer function (5.7) can be modified to the form in 





+ε=        (5.8) 
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If there are no modeling errors, M and P are identical, and the NIMC structure 
simplifies to the standard implementation in Fig. 5.1(a). The closed-loop system under 
the controller equation (5.5) will be internally stable, if the process is minimum-phase 
and asymptotically stable (Hu and Rangaiah, 1999). Advantages of the NIMC 
structure in Fig. 5.1(b) are: sensor measurement of all the states is not required as 
model M estimates the state variables and offset-free response. 
 
5.3 Implementation of NIMC for diabetic 
A nonlinear controller using input output linearization technique is developed for a 
diabetic in Simulink. The governing differential equations of the diabetic model are 
written in the form of equation (5.1). The diabetic model with NIMC structure is 
depicted in Fig. 5.2. 
 
Fig. 5.2. Nonlinear controller in NIMC structure for the diabetic system. 
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Perturbed diabetic patient, nominal diabetic patient model and nonlinear (IOL) 
controller in Fig. 5.2 corresponds to the P, M and C in the NIMC structure in Fig. 
5.1(b) respectively. The nonlinear controller is synthesized using equations (5.4 – 5.8) 
and was implemented in Simulink by employing Matlab Fcn block, which can be used 
to run a function in m-file. The Matlab Fcn in Simulink gets the states of the nominal 
diabetic model and error as the inputs from the Simulink environment and runs the 
function in m-file and the manipulated variable (i.e. insulin) as output from the m-file 
is popped back to Simulink. The coding for the implementation of the nonlinear 
controller is depicted in Fig. 5.3. The Lie derivatives and the nonlinear controller 
expression are shown in this figure. The expressions of the Lie derivatives are very 
long and only some part is visible in lines 10 to 14 of Fig. 5.3. 
 
Fig 5.3. The Math Fcn block for the implementation of nonlinear controller with input 
output linearization technique 
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5.3 Evaluation 
The NIMC is synthesized for a Type I diabetic as discussed in section 5.2. The ε  in 
equation (5.8) is generally chosen to have desired closed loop time constant. In this 
study ε  value of 0.83 is used. The assessment of the designed controller is done based 
on its ability to reject the meal disturbances, while tracking normoglycemic set point 
of 81.1 mg/dl. Note that input and output scaling are not considered in the design of 
the nonlinear controller.  
 
The performance of NIMC and EIMC with parameters (λ1 = λ2 = 5 and K = 3) in 
rejecting the 10g, 30g and 50 g meal ingestion for the nominal patient case is depicted 
in Fig. 5.4, 5.5 and 5.6. These transient responses show that NIMC is able to control 
the glucose levels better than that by EIMC. From the transient response in Fig. 5.6,  





































Fig 5.4. Transient response of the nominal diabetic patient in rejecting 10 g meal 
disturbance by NIMC (solid) and EIMC (dotted). 
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the nonlinear controller is able to maintain the glucose concentration within ±2.3 
mg/dl of the set point in rejecting 50 g meal disturbance. The IAE measure observed 
in rejecting the 10 g, 30 g and 50 g meal disturbances by NIMC is reduced by 30% 
compared to that of EIMC. But the number of spikes in the insulin computed by using 
NIMC increases with the size of the meal disturbance. 


































Fig. 5.5. Transient response of the nominal diabetic patient in rejecting 30 g meal 
disturbance by NIMC (solid) and EIMC (dotted). 
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Fig. 5.6. Transient response of the nominal diabetic patient in rejecting 50 g meal 
disturbance by NIMC (solid) and EIMC (dotted). 
 
The spikes observed in the insulin profile in rejecting meal disturbances could be 
attributed to the numerical problems in the ode15s solver. Implementation of NIMC is 
done in two different ways. One is completely implemented in Simulink, other by 
using Matlab Fcn in Simulink to run a m-file to calculate manipulated variable. But 
spikes do appear in both of these implementations. The computational time required 
for the application of nonlinear controller to perturbed cases is high. The stiffness of 
the perturbed cases causes the selection of smaller step size in ode15s solver, which 
results in higher computational time and more spikes and abnormal termination in 
some cases while rejecting the meal disturbances. Thus the performance of the 
nonlinear controller for perturbed cases in rejecting the meal disturbances could not 
be studied. 
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5.4 Summary 
Nonlinear internal model controller synthesis using input output linearization 
technique is summarized and developed. The designed controller is assessed based on 
its ability to track the normoglycemic set point in the presence of 10 g, 30 g and 50 g 
meal disturbances. Better performance in glucose regulation by nonlinear controller 
over enhanced internal model control (with K = 3) is observed for the case of nominal 
patient model. But the nonlinear controller could not be studied for all perturbed 




Conclusions and Recommendations 
6.1 Conclusions 
Several model-based controllers for blood glucose regulation in Type I diabetics are 
designed and studied using a detailed and recent physiological model. A meal 
disturbance model is also included. First, IMC and EIMC are designed using the 
FOPTD approximation of the nominal patient model and their robustness is evaluated 
for regulation of blood glucose in 577 patient models obtained by considering ±40% 
variation in the parameter values of the nominal patient model. The EIMC is able to 
maintain the glucose concentration above the dangerous hypoglycemic range in 93% 
of 577 patient models tested while rejecting meal disturbance. For these patient 
models, average IAE and standard deviation of IAE are reduced by a factor of 2 to 3 
by the EIMC compared to the conventional IMC. Further, the performance of the 
former is found to be better than that of an H∞ controller proposed by                    
Parker et al. (2000). The EIMC is further tested on all 577 perturbed patient models 
taking four meals per day, and the controller is able to maintain the blood glucose 
above the dangerous hypoglycemic range in 93% of the cases, which is the same 
number of cases as for the single meal. Thus, the EIMC strategy is attractive for blood 
glucose regulation owing to its simple structure and design as well as good robustness. 
 
The performance and robustness of PID controllers obtained using four tuning 
methods are investigated for maintaining blood glucose in all the 577 perturbed 
patient models. Controller parameters have been determined using a FOPTD 
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approximation of the detailed physiological model for the nominal patient. The recent 
tuning method by Shen (2002) outperformed the other three tuning methods (i.e., IAE 
minimization for disturbance rejection, Cohen-Coon and DMC-based) both in 
disturbance rejection and robustness characteristics. The PID controller tuned by it is 
able to maintain blood glucose above the dangerous hypoglycemic range in 95% of 
577 patient models tested for rejecting disturbances due to both single meal and four 
meals in a day. For the single meal disturbance, the average IAE and standard 
deviation of IAE are reduced by half when the PID controller is tuned by the Shen's 
method compared to controllers tuned by IAE minimization for disturbance rejection 
and Cohen-Coon; the reduction is by a factor of about 5 when compared to DMC-
based tuning. 
 
The superiority of the Shen's (2002) method over the other tuning techniques 
including IAE minimization, may be due to the ability of the optimization algorithm 
(i.e., genetic algorithm) to find the global optimum, use of equally weighted IAE due 
to set point change and load disturbance, and/or a more appropriate structure of the 
tuning correlations. Controller gain is observed to play a vital role for disturbance 
rejection in diabetics. Superior performance in disturbance rejection and robustness, 
of the PID controller tuned by Shen's (2002) method over EIMC is observed. Further 
fine tuning of this PID controller is able to maintain the blood glucose above the 
hypoglycemic range in all the 577 perturbed patient models considered. Thus, the PID 
controller is very attractive for blood glucose regulation owing to its simplicity, 
proven usage and good robustness. 
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Nonlinear internal model controller (NIMC) using input-output linearization is also 
developed and implemented for a Type I diabetic. This controller performance in 
rejecting meals of different size taken by the nominal diabetic patient model is studied 
and found to be better than that by the EIMC and PID controllers. However, spikes 
occur in the profile of the insulin injected (manipulated variable), which may be due 
to numerical problems associated with solving differential equations. Owing to this, 
NIMC could not be tested on all the perturbed patient models.  
 
6.2 Recommendations for Further Study 
The "closed-loop" device to monitor and administer insulin consists of sensor, control 
algorithm and insulin pump. Glucose sensing is possible through intra-venous 
sampling or subcutaneous measurement, and glucose measurements are available with 
a sampling interval of several minutes. Also,the diabetic model should include the 
effect of exercise on glucose dynamics. Future work on designing and evaluating 
model-based controllers for blood glucose regulation should address and include these 
practical aspects. 
 
Recently, Ruiz-Velazquez et al. (2004) have formulated blood glucose regulation for 
diabetics as a tracking problem to track the glucose profile of healthy patients 
subjected to meal disturbances. They studied the performance of H∞ controller for 
tracking the specified set-point profile. The model-based controllers considered in the 
present work and model predictive controllers can be studied for tracking the glucose 
profile in diabetics. 
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Relations in the four methods of PID controller tuning used in this study, are summarized 






. These relations provide 
values of Kc, τI and τd which can then be employed to calculate KP, KI and KD in equation 
(3) from   KP = Kc, KI = Kc/τi and KD = Kcτd. 
 
























θτ=τ   
where a1 = 1.435, a2 = 0.878, a3 = 0.482, b1 = -0.921, b2 = 0.749 and b3 =1.137. 
 




































DMC based PID tuning (Haeri, 2002): 
 ττ=τττ=τ= ddiiCc ~,~,K
K~K , τ
θ=L ;  
 64.0
L82.7L33.21
84.6)L(K~ 5.37.0c +++=  
 i~τ  = 0.95+2.58L+3.57L2 for 0 < L ≤ 0.29 


















+=τ   for 79.1L0 ≤<  
  = 0.87L-0.49L2+0.09L2.8    for 1.79<<L<4 
Shen tuning formula (Shen, 2002):  
 These tuning formula for disturbance rejection are given by: 
             τ
θ=α K  and τ+θ
θ=T  
where αKc, τi/θ and τd/θ are given by empirical correlation of the form: exp(a0+a1T+a2T2) 
and the coefficients, a's are given in the following table.  
 
 A0 a1 a2
αKc 2.94 -11.63 11.15 
τi/θ 1.88 -3.63 0.86 
τd/θ -0.25 -0.06 -1.99 
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